Evidence map›Paper›PMID 35550518›Full record

ArticleNature communications2022

Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.

Congyi Lu, Akanksha Mahajan, Sung-Hyeok Hong, Susana Galli, Shiya Zhu, Jason U Tilan, Nouran Abualsaud, Mina Adnani, Stacey Chung, Nada Elmansy and 15 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. TargetingPharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 3 countries.

Congyi Lu *Department of Physiology and Biophysics, Georgetown University, Washington, DC, USA.
Akanksha Mahajan *Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Sung-Hyeok Hong *Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Susana GalliDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Shiya ZhuDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Jason U TilanDepartment of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA.ORCID http://orcid.org/0000-0002-0454-5409
Nouran AbualsaudDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Mina AdnaniDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Stacey ChungDepartment of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA.ORCID http://orcid.org/0000-0001-5468-0361
Nada ElmansyDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Jasmine RodgersDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Olga RodriguezDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Christopher AlbaneseDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Hongkun WangDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA.
Maureen ReganGenome Editing Core, University of Illinois, Chicago, IL, USA.
Valerie ZgoncLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jan BlancatoDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Ewa KrawczykCenter for Cell Reprogramming, Georgetown University Medical Center, Washington, DC, USA.
G Ian GallicanoDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Michael GirgisDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Amrita CheemaDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Ewa Iżycka-ŚwieszewskaDepartment of Pathology and Neuropathology, Medical University of Gdańsk, Gdańsk, Poland.
Luciane R CavalliDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Svetlana D PackLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Joanna KitlinskaDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC, USA. jbk4@georgetown.edu.
Georgetown University · USNational Institutes of Health · USGdańsk Medical University · PLUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35550518
PMCPMC9098441
OpenAlexW4280507358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.